Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | -10.00% | -.--% | -.--% |
Business Summary
Number of employees: 2
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Therapeutics
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -80.74% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -80.74% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Withrow
CEO | Chief Executive Officer | - | 86-08-24 |
Denby Greenslade
DFI | Director of Finance/CFO | - | 18-02-09 |
Kevin Phelps
BRD | Director/Board Member | 69 | 21-02-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Phelps
BRD | Director/Board Member | 69 | 21-02-22 |
Denby Greenslade
DFI | Director of Finance/CFO | - | 18-02-09 |
Michael Withrow
CEO | Chief Executive Officer | - | 86-08-24 |
Allan Echino
BRD | Director/Board Member | - | 21-12-19 |
Brian Elliott
BRD | Director/Board Member | - | 22-03-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,762,363 | 16,587,030 ( 52.22 %) | 0 | 52.22 % |
Company contact information
AREV Life Sciences Global Corp.
91 Golden Drive Suite 18
V3K 6R2, Coquitlam
+
http://arevlifesciences.comSector
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.09M | |
+8.20% | 7.78B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- AREV Stock
- Company AREV Life Sciences Global Corp.